<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="84041">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01988649</url>
  </required_header>
  <id_info>
    <org_study_id>STU00086297</org_study_id>
    <nct_id>NCT01988649</nct_id>
  </id_info>
  <brief_title>Oxytocin and Pain Sensitivity and Threshold</brief_title>
  <official_title>The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold: A Randomized, Double Blinded, Crossover Volunteer Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxytocin is neurohypophysial peptide that acts mainly as a neuromodulator in the brain. In
      addition,oxytocin have an important roles in sexual reproduction , in particular during and
      after childbirth. It facilitates birth, maternal bonding, and, breastfeeding. Nasal oxytocin
      has been commonly used to improve breastfeeding in lactating women. A review of safety ,
      side effects and subjective reaction to intranasal oxytocin in human research in 1529
      subjects did not review any differences from placebo. The vast majority of basic science
      studies suggested a large effect of  oxytocin in minimizing acute pain.4 Few studies have
      demonstrated an association between plasma levels of oxytocin and pain in humans. No studies
      have examined the effect of intranasal oxytocin on pain sensitivity and threshold. Since
      addictive properties of oxytocin have not been described, the drug may have important
      application in the management of acute and chronic pain.

      The main objective of the current investigation was to evaluate the effect of intranasal
      oxytocin on pain sensitivity and threshold in human volunteers. We hypothesized that
      intranasal oxytocin, in human volunteers ,would decrease sensitivity and and increase pain
      threshold compared to intranasal saline .

      Significance: Intranasal oxytocin may become a viable treatment for acute and chronic pain
      in humans.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Pain sensitivity and threshold</measure>
    <time_frame>120 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain sensitivity and threshold using the MEDoc device. Mechanical and thermal pain test will be performed at baseline, before drug administration, at 45 minutes and at 90 minutes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects of Oxytocin</measure>
    <time_frame>2 Hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Side effects  including running nose, nasal irritation, tears in the eyes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pai</condition>
  <arm_group>
    <arm_group_label>Intranasal Oxytocin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of 32 units of Oxytocin administered intranasally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (saline)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of 4 sprays intranasally of normal saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal Oxytocin</intervention_name>
    <description>Administration of intranasal Oxytocin</description>
    <arm_group_label>Intranasal Oxytocin</arm_group_label>
    <other_name>Oxytocin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (saline)</intervention_name>
    <description>Administration of normal saline intranasally.</description>
    <arm_group_label>Placebo (saline)</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males and females volunteers

          -  English speaking

          -  Age &lt;20 and &gt; 35

        Exclusion Criteria:

          -  Pregnancy

          -  Lactation

          -  Allergy to preservatives

          -  Mental disease

          -  Chronic pain

          -  Current use of analgesics

          -  Anxiety or depression Drop Out: volunteer request
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gildasio De Oliveira, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gildasio De Oliveira, MD, MS</last_name>
    <phone>312-472-3573</phone>
    <email>g-jr@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert McCarthy, PharmD</last_name>
    <phone>312-695-4976</phone>
    <email>r-mccarthy@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gildasio De Oliveira, MD, MS</last_name>
      <phone>312-472-3573</phone>
      <email>g-jr@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Gildasio De Oliveria, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yamasue H, Yee JR, Hurlemann R, Rilling JK, Chen FS, Meyer-Lindenberg A, Tost H. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci. 2012 Oct 10;32(41):14109-17. doi: 10.1523/JNEUROSCI.3327-12.2012. Review.</citation>
    <PMID>23055480</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 23, 2014</lastchanged_date>
  <firstreceived_date>November 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Gildasio De Oliveira</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Oxytocin</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
